Skip to content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC

  • Chunlei Ge1,
  • Ruilei Li1,
  • Haifeng Song1,
  • Tao Geng1,
  • Jinyan Yang1,
  • Qinghua Tan1,
  • Linfeng Song1,
  • Ying Wang1,
  • Yuanbo Xue1,
  • Zhen Li1,
  • Suwei Dong1,
  • Zhiwei Zhang1,
  • Na Zhang1,
  • Jiyin Guo1,
  • Lin Hua1,
  • Siyi Chen2, 3, 4Email author and
  • Xin Song1Email author
Contributed equally
BMC Cancer201717:884

https://doi.org/10.1186/s12885-017-3859-3

Received: 15 July 2016

Accepted: 29 November 2017

Published: 21 December 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
15 Jul 2016 Submitted Original manuscript
8 Feb 2017 Reviewed Reviewer Report - Abhishek Garg
14 Feb 2017 Reviewed Reviewer Report - Shigetaka Shimodaira
18 Feb 2017 Reviewed Reviewer Report - Tuncay Göksel
24 Jul 2017 Author responded Author comments - Chunlei Ge
Resubmission - Version 2
24 Jul 2017 Submitted Manuscript version 2
28 Jul 2017 Reviewed Reviewer Report - Abhishek Garg
29 Nov 2017 Author responded Author comments - Chunlei Ge
Resubmission - Version 3
29 Nov 2017 Submitted Manuscript version 3
Publishing
29 Nov 2017 Editorially accepted
21 Dec 2017 Article published 10.1186/s12885-017-3859-3

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Cancer Biotherapy Center, The Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, China
(2)
Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, USA
(3)
Department of Immunology, Baylor College of Medicine, Houston, USA
(4)
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, USA

Advertisement